Healthcare provider profile · identity verified

Barbara Kevish Saltrelli

Family Practice · HILTON HEAD ISLAND, SC · NPI 1922055946

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	483	128
Levothyroxine Sodium	Levothyroxine Sodium	300	77
Amlodipine Besylate	Amlodipine Besylate	228	58
Lisinopril	Lisinopril	219	50
Pantoprazole Sodium	Pantoprazole Sodium	178	42
Omeprazole	Omeprazole	155	39
Losartan Potassium	Losartan Potassium	154	45
Hydrochlorothiazide	Hydrochlorothiazide	150	42
Jardiance	Empagliflozin	140	25
Sertraline Hcl	Sertraline Hcl	137	39
Eliquis	Apixaban	136	23
Simvastatin	Simvastatin	130	39
Fluticasone Propionate	Fluticasone Propionate	114	36
Clopidogrel	Clopidogrel Bisulfate	107	18
Metoprolol Tartrate	Metoprolol Tartrate	106	33
Metoprolol Succinate	Metoprolol Succinate	92	31
Metformin Hcl Er	Metformin Hcl	86	26
Gabapentin	Gabapentin	85	30
Trazodone Hcl	Trazodone Hcl	79	22
Memantine Hcl	Memantine Hcl	77	suppressed
Alendronate Sodium	Alendronate Sodium	75	30
Rosuvastatin Calcium	Rosuvastatin Calcium	74	25
Metformin Hcl	Metformin Hcl	69	19
Allopurinol	Allopurinol	66	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	suppressed
Pravastatin Sodium	Pravastatin Sodium	65	18
Finasteride	Finasteride	63	suppressed
Furosemide	Furosemide	62	25
Famotidine	Famotidine	59	25
Xarelto	Rivaroxaban	57	11
Montelukast Sodium	Montelukast Sodium	56	12
Mirtazapine	Mirtazapine	53	18
Meloxicam	Meloxicam	50	19
Ozempic	Semaglutide	50	11
Paroxetine Hcl	Paroxetine Hcl	47	11
Potassium Chloride	Potassium Chloride	45	15
Chlorthalidone	Chlorthalidone	42	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	11
Tamsulosin Hcl	Tamsulosin Hcl	40	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	11
Citalopram Hbr	Citalopram Hydrobromide	37	11
Atenolol	Atenolol	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Azelastine Hcl	Azelastine Hcl	29	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	13
Spironolactone	Spironolactone	27	suppressed
Bupropion Xl	Bupropion Hcl	26	11
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Irbesartan	Irbesartan	25	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	suppressed
Methylprednisolone	Methylprednisolone	21	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Valsartan	Valsartan	19	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	18	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Prednisone	Prednisone	18	14
Triamcinolone Acetonide	Triamcinolone Acetonide	18	11
Estradiol	Estradiol	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	15	suppressed
Topiramate	Topiramate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error